Brief: Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10582 Tablets
06/08/2026 18:22
BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10582 Tablets Aug 6 (Reuters) - Hansoh Pharmaceutical Group Company Limited 3692.HK:
CLINICAL TRIAL APPROVAL FOR HS-10582 TABLETS ISSUED BY- NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion